The currency displayed has been switched according to the country of your account. The items in your cart will now appear in NZD.

You successfully switched to NZD currency. The items in your cart will now appear in NZD.

PRICE ADJUSTMENT: Prices are changing on December 15—shop today to save on assessments and training. Shop now!

${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, order history and Q-global ordering for both accounts are now accessible via the ${winnerAccount} account. If something isn’t right, please contact us.

Frenchay Dysarthria Assessment 2 Edition

FDA-2
  • Pamela Enderby
  • Rebecca Palmer
Measurement, differential description, and diagnosis of dysarthria
PCTA distributes but does not publish this product.

Choose from our formats

  • Kits

    Starter & complete kits, print & digital

    1 option

    From AUD 422.62
    From AUD 422.62
  • Test forms & reports

    Booklets, record forms, answer sheets, report usages & subscriptions

    1 option

    From AUD 128.92
    From AUD 128.92
  • Support materials

    Manuals, stimulus books, replacement items & other materials

    1 option

    From AUD 131.12
    From AUD 131.12
  • All products

    All tests and materials offered for FDA-2

    3 options

    From AUD 128.92
    From AUD 128.92
    Filter by
    - of 3 results
    Prices include GST where applicable
    • FDA 2 Complete Kit
      12685 Qualification Level B

      Includes:

      • Examiners Manual
      • 25 Rating Forms
      • Intelligibility Cards

      AUD 422.62

      text.product.itembackinstockonpurchaseinfo

    • FDA-2 Rating Forms
      12687 Qualification Level B

      Pack of 25

      AUD 128.92

      text.product.itembackinstockonpurchaseinfo

      Estimated to ship:2-3 weeks
    • FDA-2-Intelligibility Cards
      12688 Qualification Level B

      AUD 131.12

      text.product.itembackinstockonpurchaseinfo

      Estimated to ship:4-5 weeks
    - of 3 results

    Overview

    Publication date:
    2008

    Completion time:
    20 minutes

    Administration:
    Individual

    Age range:
    12 years to adult

    Qualification level:
    B

    Qualification Level

    Level A

    This approval level enables you to buy our assessments that require no professional degree, accreditation, organization membership, or license/certificate.

    Level B

    This approval level enables you to buy our assessments requiring A or B qualification levels.

    Level C

    This approval level enables you to buy all our assessments.

    Product Details

    The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria. It can be used in research, as well as all clinical settings.

    FDA-2 is quick and simple to administer, accurate, reliable, and cost-efficient. The client is rated on a number of simple performance tasks related to speech function. It is divided into eight sections:

    1. Reflexes - ratings for cough, swallow, and dribble/drool
    2. Respiration - ratings at rest and in speech
    3. Lips - ratings for at rest, spread, seal, alternate, and in speech
    4. Palate - ratings for fluids, maintenance, and in speech
    5. Laryngeal - ratings for time, pitch, volume, and in speech
    6. Tongue - ratings for at rest, protrusion, elevation, lateral, alternate, and in speech
    7. Intelligibility - ratings for words, sentences, and conversation
    8. Influencing Factors - includes hearing, sight, teeth, language, mood, posture, rate (words per minute), and sensation

    The test results can be recorded on the FDA-2 Rating Form, indicating both the clients strengths and weaknesses. The Rating Form also allows the clinician to compare the clients performance across all the items. Normative data are reported for adults without dysarthria as well as patients with specific dysarthria associated with confirmed medical diagnoses.